Key facts
- This page summarizes Leone D. Patterson's Form 4 filing for Zymeworks Inc. (ZYME).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Jan 2025, 18:11.
Leone D. Patterson - 10 Jan 2025 Form 4 Insider Report for Zymeworks Inc. (ZYME)
- Reporting relationship
- EVP, Chief Bus & Fin Officer
- Issuer ticker
- ZYME
- Reported as of
- 10 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2025, 18:11:32 UTC
- Prior SEC filing
- 03 Sep 2024
- Next SEC filing
- 04 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Dex, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Leone D. Patterson filed Form 4 for Zymeworks Inc. (ZYME) on 10 Jan 2025.
Change
- Previous filing in this sequence was filed on 03 Sep 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZYME
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +79,000
- Change %
- Price
- $0.000000
- Shares after
- 79,000
- Date
- 10 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 79,000
- Exercise price
- $13.22
- Footnotes
- F1
ZYME
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +53,000
- Change %
- Price
- $0.000000
- Shares after
- 53,000
- Date
- 10 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 53,000
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date.
Footnote F2
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of Issuer's common stock.
Footnote F3
RSUs vest in three equal annual installments beginning on first anniversary of grant date.